The latest from Redeye about Scandinavian Life Science and Technology companies

Theme: Online Gambling

Get in the game and place your bets!

Find out more

Theme: Cybersecurity

Cyberattacks on the rise - Can we win the battle?

Find out more

Theme: Gaming

Super Investment Gaming Guide - In depths on the bits and pixels of the Gaming industry. GLHF

Find out more

Theme: Fight Cancer

There is a war on cancer and now, for the first time ever we see an opportunity for winning.

Find out more

Starbreeze

StarVR Corp's börsnotering

Research Note 2018-04-23
STAR B
icon-company Starbreeze

StarVR Corp's börsnotering

Research Note 2018-04-23 Tomas Otterbeck

Vi kommenterar nyheten att StarVR Corp noterats på den mindre kinesiska listan "Taipei Exchange" där börsvärdet pendlat mellan 964-1313 miljoner kronor under dagen. Vi höjer vår DCF-värdering i vårt så kallade basscenario.

Continue reading

Sprint Bioscience

Mot klinik

Research Update 2018-04-17
SPRINT
icon-company Sprint Bioscience

Mot klinik

Research Update 2018-04-17 Arvid Necander

Denna analys behandlar innebörden av avancemang inom PIP4K2A-projektet och en genomförd företrädesemission, samt de modelluppdateringar händelserna har medfört.

Continue reading

XMReality

Fully focused on ramp-up

Research Update 2018-04-22
XMR
icon-company XMReality

Fully focused on ramp-up

Research Update 2018-04-21 Dennis Berggren

XMReality reported somewhat lower sales than expected in Q1. Sales are, however, still on a low level and heavily affected by delivery of individual orders. We perform minor adjustments of our short-run estimates while our view of the long-term case is intact.

Continue reading

Ericsson

Positiv utveckling

Research Note 2018-04-20
ERIC B
icon-company Ericsson

Positiv utveckling

Research Note 2018-04-20 Greger Johansson

Ericsson annonserade nu på morgonen sin Q1-rapport som innehöll i huvudsak positiva nyheter. Det mest positiva i rapporten var att bolaget visade på en mycket bra justerad bruttomarginal och därmed ett bra justerat resultat.

Continue reading

Nitro Games

Higher costs than expected in Q1

Research Note 2018-04-20
NITRO
icon-company Nitro Games

Higher costs than expected in Q1

Research Note 2018-04-20 Tomas Otterbeck

Nitro Games quarterly result was below our expectations. EBITDA in the quarter was among other things affected by more aggressive spending in user acquisition.

Continue reading

Episurf Medical

Analytikerintervju med Anders Hedlund

Research Interview 2018-04-12
EPIS B
icon-company Episurf Medical

Analytikerintervju med Anders Hedlund

Research Interview 2018-04-11 Anders Hedlund

Redeye inleder bevakning av Episurf Medical och i en intervju tar vår analytiker Anders Hedlund upp de viktigaste faktorerna framöver samt hur han ser på värderingen.

Continue reading

Events

24

Apr

Investor After Work Stockholm 24 april

25

Apr

InDex Pharmaceuticals kapitalmarknadsdag (English)

26

Apr

Quarterly report presentation and Q&A - Bredband2

Announcements

Redeye Corporate Finance söker projektledare med intresse för gaming och betting

Redeye bistår Annexin Pharmaceuticals i fullt garanterad företrädesemission

Redeye bistår Teqnion i övertecknad private placement

You need to be a Redeye member to access this content

Become a member to:

By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions